US Food and Drug Administration (FDA) has approved Ctexli (chenodiol) tablets, a bile acid, for the treatment of adults with cerebrotendinous xanthomatosis (CTX). Ctexli is the first and only ...
Japanese MHLW approves Sarclisa for patients with newly diagnosed multiple myeloma: Paris Wednesday, February 26, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour and Welfare ...
Nandita Vijayasimha, Bengaluru Wednesday, February 26, 2025, 08:00 Hrs [IST] ...
Peethaambaran Kunnathoor, Chennai Wednesday, February 26, 2025, 08:00 Hrs [IST] ...
The International Pharmaceutical Excipients Council Federation, (IPEC Federation) has now announced the availability of the revised IPEC Incorporation of Pharmaceutical Excipients into Product ...
The Central Drugs Standard Control Organisation (CDSCO) has renamed its post licensure monitoring division as Post Marketing Drugs Safety Monitoring Division (PMDSMD), with immediate effect. The ...
Though the industry as a whole had welcomed the implementation of Revised Schedule M, the MSMEs have since been demanding to the government that a minimum of three years may be needed for the MSMEs to ...
Nektar Therapeutics and TrialNet, an international clinical trial network at the forefront of diabetes research, announced a new collaboration agreement to evaluate Nektar's rezpegaldesleukin in ...
Indivior PLC, a global leader in addiction treatment, announced that the US Food and Drug Administration (FDA) has approved label changes for Sublocade including a rapid initiation protocol and ...
Merck Life Science opens formulation & technology centre in Turbhe, Navi Mumbai: Our Bureau, Bengaluru Tuesday, February 25, ...
EY-Parthenon & Microsoft report charts path to enterprise adoption at BioAsia 2025: Our Bureau, Bengaluru Tuesday, February 25, 2025, 16:15 Hrs [IST] EY-Parthenon and Microsoft ha ...